Published on 6 Oct 2022 on Zacks via Yahoo Finance
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ChemoCentryx (CCXI) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
ChemoCentryx is a member of our Medical group, which includes 1193 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ChemoCentryx is currently sporting a Zacks Rank of #2 (Buy).